Source: Tether Strategic Stake in Blackrock Neurotech
source confidence: High status: Useful updated 2026-05-09
Summary
April 2024 announcement of Tether's $200 million strategic investment in Blackrock Neurotech through Tether Evo, the company's emerging-technologies venture arm. The release describes the investment as making Tether the majority stakeholder in Blackrock and frames the use of funds around clinical commercialization and continued R&D.
Useful Claims
- Tether announced a $200 million strategic investment in Blackrock Neurotech in April 2024.
- The investment was made through Tether Evo, Tether's venture arm for emerging technologies.
- The release states that the investment made Tether the majority stakeholder in Blackrock Neurotech.
- The release identifies Blackrock as a Salt Lake City–based BCI company founded in 2008 by Dr. Florian Solzbacher and Marcus Gerhardt.
Reliability Notes
Useful for the existence, size, and majority-stake framing of the investment. The strategic and governance implications for an FDA-regulated medical-device company under crypto-treasury ownership are not addressed and should be triangulated against later corporate disclosures. As an investor press release, treat use-of-funds language as intent rather than verified outcome.